"An important clinical trial for Parkinson’s disease has just gotten underway in UK. The placebo-controlled Phase III trial will test whether a long-existing cough medication can slow down the progression of the neurodegenerative condition & improve people’s quality of life. Earlier studies have suggested that the drug can interact with brain proteins key to the development of Parkinson’s. The drug is called #ambroxol - https://gizmodo.com/cough-medicine-ambroxol-parkinsons-disease-trial-1849986729 #ParkinsonsDisease #NeurodegenerativeDiseases